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In this project we investigated the incidence of diarrhea and its possible causes in 
ventilator dependent patients in the intensive care unit (ICU) at McKay-Dee Hospital. 
Chronic diarrhea has been a long time problem in the ICU, but the etiology has never 
been fully explored. High dose antibiotic therapy has been thought to be a potential risk 
factor . Another proposed risk has been the use of glutamine, a conditionally essential 
amino acid contained in some enteral products. Glutamine is commonly used in feeding 
critically ill patients because of its immune enhancing properties. 
Currently, we have not established a correlation between the use of glutamine and 
the incidence of diarrhea. Data obtained in this study, however, suggests that a correlation 
exists with high-dose antibiotic therapy. 
Future application of this research could lead to standard protocols in treatment of 
diarrhea in the ICU. Such protocols might include all patients administered high dose 
antibiotic therapy be given a probiotic supplement to prevent diarrhea. Also, if further 
evidence is found between glutamine supplementation and increased risk of diarrhea, 
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INTRODUCTION 
This was a retrospective chart review conducted at McKay-Dee Hospital in Ogden, Utah 
during the period of January 2006 to December 2006 to determine risk factors for diarrhea. The 
intent of this study was to verify if glutamine supplementation is associated with diarrhea in 
ventilator dependent patients in the intensive care unit. 
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REVIEW OF LITERATURE 
Diarrhea in the Intensive Care Unit 
It has been estimated that about one-third of patients admitted to the intensive care unit 
(ICU) develop diarrhea during their hospitalization. The most common factors that have been 
attributed to diarrhea include the use of antibiotic therapy, enteral feedings, and clostridium 
difficile infection ( 1 ). Smith et al. (2) found that 63% of critically ill adult patients who required 
mechanical ventilation experienced diarrhea associated with enteral nutrition (2). It was 
concluded this was from improper administration of enteral products. Higher osmolarity and 
infusion rates of enteral products contributed to an increased incidence and longer duration of 
diarrhea (2). It has been estimated that 5% of reported diarrhea in ICU patients is attributed to 
mechanical ventilation (3). 
Diarrhea can lead to further complications such as volume depletion and wound 
infection, which can considerably increase medical cost. Wu et al. (3) demonstrated that the 
average length of stay in the ICU with complications of diarrhea was 8 days (3). The estimated 
average cost per day ofICU care for the hospital is 6,000-7,000 dollars. In comparison, the 
length of stay was only 4 days for those without complications of diarrhea (3). This supports the 
rational that preventing diarrhea will decrease medical costs and ultimately provide optimal 
health care for the patient. 
Antibiotic Associated Diarrhea 
Antibiotic associated diarrhea occurs in up to 25% of patients receiving antibiotics. Diarrhea 
related to antibiotic use can occur after a single dose or may persist as long as 6 weeks after 
discontinuing antibiotic therapy. The most commonly diagnosed and potentially severe form of 
antibiotic associated diarrhea is caused by Clostridium difficile , accounting for 15% to 25% of 
antibiotic associated diarrhea. The human digestive tract is host to a vast of microbes and 
harbors more than 500 identified species. Some of these bacteria are essential for health. To 
prevent bacterial invasion, the mucosa of the gastrointestinal tract functions as a barrier to 
numerous pathogens ( 4 ). Antibiotics alter the normal fecal flora, which predisposes the gut to 
colonization by potentially pathogenic microbes, such as Clostridium difficile (5). 
One method to treat antibiotic associated diarrhea and Clostridium difficile infection is 
use of probiotics. Probiotics are live microbial food supplements or components of bacteria that 
affect the host by improving microbial balance, and have been used as a way of restoring 
beneficial intestinal microbes. The possible advantages of probiotics as therapeutic agents are 
that they can lower the dependence on antibiotic use, decrease antibiotic associated diarrhea, are 
relatively inexpensive , and are generally considered safe and well tolerated (5). 
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Currently , there are numerous forms of probiotics used in diarrhea prevention. One 
particular probiotic that has been researched extensively is Saccharomyces boulardii . There is 
evidence to support the use of Saccharomyces boulardii in the prevention of antibiotic associated 
diarrhea at a dose of 1 gram daily in hospitalized adults. Surawicz et al. ( 6) treated 180 
hospitalized patients , who were administered antibiotics , with 1 gram of Saccharomyces 
boulardii daily or were administered a placebo (6). The patients continued treatment for 2 weeks 
after the last antibiotic dose was given. Of the 180 patients , 21.8% of placebo treated patients 
developed diarrhea, compared with 9.5% of patients treated with Saccharomyces boulardii (6). 
There is no support for prophylactic probiotic treatment to prevent an initial infection of 
Clostridium difficile, but Saccharomyces boulardii can be used to decrease its recurrences ( 4). 
Future application ofthis research could lead to standard protocols in treatment of diarrhea in the 
ICU. Such protocols might include all patients administered high dose antibiotic therapy be 
given a probiotic supplement to prevent antibiotic-associated diarrhea. 
Glutamine 
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Infection often occurs among critically ill patients. Infection contributes to increased 
morbidity, mortality, and healthcare costs. Several therapies that may reverse 
immunosuppression have been identified. One such therapy is glutamine supplementation and is 
often added to enteral and parenteral products (7). 
Over the past 20 years, glutamine has been reported to help maintain acid-base balance, 
act as a primary fuel source for rapidly dividing cells, preserve integrity of gastrointestinal 
mucosa, act as a substrate for purines and pyrimidines bases, synthesize glutathione and arginine, 
and function as a key substrate for gluconeogensis (8). 
Human studies have shown that glutamine supplementation can help decrease 
infection, gram-negative bacteremia, nitrogen losses, and ventilator days, resulting in a decrease 
in hospital length of stay and total healthcare cost (9). In a randomized, controlled clinical trial 
in ICU patients, of which 71 % were septic, glutamine supplementation resulted in a 24% 
decrease in mortality (10). The positive effect of glutamine on morbidity related to infection was 
also validated by a meta-analysis comparing the use of glutamine supplementation in surgical 
and critically ill patients. There were 14 randomized trails included in this study that evaluated 
the effect of glutamine versus standard care on clinical outcomes (11 ). The results showed a 
reduced length of hospital days ( on average a decrease of 2.6 days). In surgical patients 
glutamine supplementation was associated with few infectious complications but no effect on 
mortality was found. In critically ill patients glutamine supplementation was associated with a 
reduction in infectious complications and improved morality rate (11). 
Glutamine is the most abundant amino acid in the body. It comprises 60% of the total 
free amino acid pool. Much of the nitrogen transport from the skeletal to the visceral tissues is 
via glutamine (8). Under normal physiologic conditions, glutamine is synthesized from 
glutamate and glutamic acid by glutamate-ammonia ligase and is therefore considered 
nonessential. However, it has been suggested that glutamine may become a conditionally 
essential amino acid for patients in a catabolic state (11 ). 
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During periods of increased metabolic stress, glutamine is released freely from skeletal 
muscle and intracellular glutamine concentrations fall by more than 50% (11 ). As a result, 
during periods of catabolism glutamine synthesis cannot meet physiologic needs. Dietary 
protein via oral or enteral routes provides only maintenance levels of glutamine. Furst et al. (12) 
stated that during periods of stress, 15 to 35 grams of supplemented glutamine may be needed to 
preserve muscle glutamine stores, maintain gut integrity, provide fuel for cells with rapid 
turnover, and improve overall nitrogen balance (12). 
The mechanism that explains the role of glutamines benefit during critical illness is 
related to its interaction with arginine. One theory suggests that glutamine increases arginine 
synthesis in the kidneys. Arginine aids in wound healing and is the precursor to nitric oxide. 
Nitric oxide regulates blood flow through vital organs and is particularly critical during stress. 
Thus, glutamine may be important in regulating blood flow by serving as a precursor to arginine 
(13). 
Recent evidence suggests that glutamine can induce heat shock proteins. Heat shock 
proteins are a class of cellular chaperone proteins that support appropriate protein folding during 
ribosomal translation. These proteins prevent poorly folded intracellular proteins. 
Supplementation with glutamine increases production of heat shock proteins, enhancing cellular 
ability to protect against stress (8, 9). It has been found that individuals deficient in glutamine 
manifest changes in gut morphology including increased membrane permeability resulting in 
bacterial translocation, malabsorption, and diarrhea. 
Dosing parameters for oral and enteral glutamine have varied widely over the years. 
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Current research has generally used 0.5 grams of glutamine per kilogram of actual body weight. 
This level is thought to be sufficient to provide for the increase in glutamine required during 
metabolic stress. Doses lower than 0.285 grams per kilogram of actual body weight has been 
found to convey no benefit over standard feedings. It is also recommended that glutamine 
dosing should be divided throughout the day to increase contact with enterocytes (8). 
Glutamine Supplementation and Diarrhea 
Recently, glutamine supplementation has been investigated to determine its relationship 
to the incidence of diarrhea in the ICU. However, prior studies have not established a consistent 
association between incidence of diarrhea and glutamine supplementation. One reason for this is 
the very limited amount of research conducted in this area. In fact, there is no research published 
to date that specifically has focused on this relationship. Until more research is gathered, debate 
will continue on the association between glutamine supplementation and diarrhea. Some studies 
have been conducted to determine the efficacy and safety of glutamine supplementation. It has 
been reported that no adverse effects of glutamine have been observed when administered doses 
of 50-60 grams of glutamine per day (14). However, there is evidence that protein intake, 
greater than 200 grams per day, might be toxic. Furthermore, a consumption of more than about 
40% of daily energy intake from protein sources can result in nausea and diarrhea (14). Because 
glutamine is metabolized to glutamate and ammonia, both of which have known neurological 
effects, psychological and behavioral status should be monitored while on high doses of 
glutamine (14). 
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It is of interest that dosing parameters for oral and enteral glutamine have varied widely 
over the years. Current research has generally used 0.5 grams of glutamine per kilogram of 
actual body weight. This level is thought to be sufficient to provide for the increase in glutamine 
required during metabolic stress. Doses lower than 0.285 grams per kilogram of actual body 
weight has been found to convey no benefit over standard feedings. It is also recommended that 
glutamine dosing should be divided throughout the day to increase contact with enterocytes (8). 
Glutamine supplementation enhances sodium and water reabsorption, and therefore 
contributes to a decrease in diarrhea symptoms. It has been reported that patients with 
inflammatory bowel disease experience decreased gastrointestinal symptoms and improved 
quality of life when glutamine supplementation is given long-term (8). Bushen et al. (15) 
conducted a study to determine the effects of glutamine therapy on diarrhea incidence in patients 
with acquired immune deficiency syndrome (AIDS) (15). Subjects that received a high-dose of 
glutamine had improved gastrointestinal symptoms. As a result, it was concluded that glutamine 
was effective in decreasing diarrhea in patients with AIDS undergoing antiretroviral drug 
treatment (15). In addition, Byrne et al. (16) found that 6 adult patients with short-bowl 
syndrome that were given a combination of growth hormone, oral or intravenous glutamine, and 
a high-fiber diet, had increased water, nitrogen, sodium and energy absorption and decreased 
stool weights compared to baseline (16). 
The proposed mechanism of the role of glutamine supplementation in diminishing 
symptoms of diarrhea could be explained by the effect glutamine has on increasing plasma 
concentrations of taurine. Taurine is an intracellular osmolyte that can regulate cell volume and 
therefore has a major influence on fluid homeostasis. It is plausible that glutamine may reduce 




The objective of this study was to establish a relationship between glutarnine 
supplementation and diarrhea in ventilator dependent patients in the intensive care unit. 
Therefore, the hypothesis that was tested is that glutarnine supplementation does not increase risk 
for diarrhea in ventilator dependent patients in the intensive care unit. 
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MATERIALS AND METHODS 
Data Collection 
This study was a retrospective chart review conducted at McKay-Dee Hospital in Ogden, 
Utah from January 2006 to December 2006 to determine risk factors for diarrhea. All study 
participants (n=l26) were admitted to the intensive care unit and placed on mechanical ventilator 
assistance. This specific population was selected due to their known immunocompromised status 
and the increased likelihood of being administered glutamine as a result (17). There were three 
participants that were excluded from the study because they had a colostomy. 
Potential variables assessed in this study were collected from the medical charting system 
used at McKay-Dee Hospital. Potential variables included, but were not limited to stool output, 
rectal tube use, glutamine supplementation, Beneprotein® supplementation, antibiotic therapy, 
use of bowel stimulants, colonic lavage therapy, and blood detected in stools. Based upon this 
information, independent variables were identified that could potentially affect the occurrence of 
diarrhea. Specific variables selected for analysis were glutamine supplementation, Beneprotein® 
supplementation, and antibiotic therapy. 
Statistical Analyses 
Contingency tables were calculated and chi-square analysis was used to compare the 
expected contingency table to the observed contingency table. Logistic regression analysis and 
modeling techniques were used to determine the associations between glutamine 
supplementation and incidence of diarrhea. Initially odds ratios were used to evaluate the 
incidence of diarrhea. The Breslow-Day test was used to assess the homogeneity of the odds 
ratios. 
The dependent variable in the models was average stool output which had two values, 
diarrhea (average stool output of 2 stools or more per day)=l and no diarrhea (average stool 
output less 2 stools per day)= 0. The dependent variable was binary (0 or 1). The independent 
variables were discrete in nature instead of continuous. 
Because of the discrete nature of the data, the data was logit transformed and logistic 
regression analysis was used. The logistic regression model used in this study was: 
Ln{Y=[Prob(diarrhea=l)]/[Prob(no diarrhea=0)]}=B0+Bl *Xl +B2*X2+ ..... +Bx*Xn 
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The X's were the independent variables. The B's were the logistic regression coefficients. 
Their estimates were represented by b's. The B's represent the original unknown parameter , 
while b was its estimate. 
The left-hand side of this relationship is known as the logit transformation of a 
probability. It is also called the log-odds ratio. The odds ratio gives the linear relationship 
between the dependent variable and the independent variable. 
All statistical analyses were conducted with SAS statistical software program (SAS 




Less than 10 days of 10 or more days of 
Total days glutamine use glutamine use Total 
of antibiotic Average of Average of2 Average of Average of2 
therapy less than 2 or more less than 2 or more 
stools/day stools/day stools/day stools/day 
0-15 25 5 4 2 36 
16-30 9 7 11 2 29 
31-45 5 1 7 1 14 
> 46 1 3 5 3 12 
Total 40 16 27 8 91 
Table 1 depicts if stool output depends on glutamine use and if this effect is modified by 
antibiotic therapy. The marginal odds-ratio is 0.74 , which may indicate that glutamine is 
inversely related to stool output. 
Table 2. 





> 46 0.2 
Yet, it appears that antibiotic therapy could be a potential confounding factor because 
antibiotic therapy appears to affect the average stool output per day according to table 2. 
However, there are small cell counts in the last 2 strata , which may have impacted the results. 
There appears to be an association between antibiotic therapy and glutamine use, but 
there appears to be no association between glutamine use and stool output. 
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The Breslow-Day test assessed the homogeneity of the odd-ratios and the result was B2 = 
4.1781 , with a p-value of 0.2449. Therefore , there is no significant difference among odds-ratios 
and the small cell counts in the last 2 strata are most likely the cause of the association and the 
differences are due to chance 
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DISCUSSION 
Although further research is warranted, this study supports the hypothesis that glutamine 
use does not increase risk for diarrhea. 
These findings also support previous research that antibiotic therapy may be related to 
frequency of stool output. As reported by Katz, antibiotic associated diarrhea occurs in up to 
25% of patients receiving antibiotics (5). 
Of greater importance to future research is the fact that this study showed that glutamine 
use does not appear to increase risk for diarrhea and in fact, may appear to have a protective 
effect. The proposed mechanism of the role of glutamine supplementation in diminishing 
symptoms of diarrhea could be explained by the effect glutamine has on increasing plasma 
concentrations of taurine. Taurine is an intracellular osmolyte that can regulate cell volume and 
therefore has a major influence on fluid homeostasis. It is plausible that glutamine may reduce 
symptoms of diarrhea due to its impact on taurine availability (13 ) . 
Our findings are in accordance with that of prior research in that there have been no 
reported adverse side effects of glutamine supplementation (14). However , this was a correlation 
study and cannot be used to unequivocally state that glutamine use is not related to diarrhea and 
may exhibit a protective effect against stool output. Furthermore, there were potential variables 
such as tube feed rate, sorbitol use, and recent gastrointestinal surgeries that may impact stool 
output that were not obtained. One limitation of this study is the small sample size. Statistical 
significance may have been achieved with a larger sample size. Consequently, continuation of 
this study should be considered to possibly obtain a stronger association. 
20 
SUMMARY 
Recently, glutamine supplementation has been investigated to determine its relationship 
to the incidence of diarrhea in the ICU. However, prior studies have not established a consistent 
association between incidence of diarrhea and glutamine supplementation. The focus of this 
study was to perform a statistical analysis on various data collected form the medical charting 
system at McKay-Dee Hospital in ventilator dependent patients to determine whether there was 
an association between glutamine supplementation and diarrhea. Although further research is 
warranted, this study supports the hypothesis that glutamine use does not increase risk for 
diarrhea. 
Findings from this study support previous research that antibiotic therapy may be related 
to frequency of stool output. There are many benefits of glutamine supplementation in critically 
ill patients. One in particular is that glutamine may exhibit a protective effect against diarrhea. 
Wu et al. ( 4) demonstrated that the average length of stay in the ICU with complications of 
diarrhea was 8 days ( 4 ). In comparison, the length of stay was only 4 days for those without 
complications of diarrhea ( 4 ). This supports the rational that preventing diarrhea will decrease 
medical costs and ultimately provide optimal health care for the patient. The results and 
conclusions derived from the data may eventually lead to standard protocols in treatment of 
diarrhea in the ICU. 
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